Publications by authors named "Hiroshi Inami"

Claim this Profile
R
Relationship Between Shoulder External Rotation and Glenohumeral Joint Alignment Changes in Baseball Players.
Makoto Takahashi, Hirotaka Mutsuzaki, Koji Iwamoto, Masahiko Monma, Makoto Nejishima, Hiroshi Inami

J Appl Biomech· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Shoulder Morphological Changes and Glenohumeral Maximum External Rotation During Late Cocking Phase.
Makoto Takahashi, Hirotaka Mutsuzaki, Koji Iwamoto, Masahiko Monma, Makoto Nejishima, Hiroshi Inami

Orthop J Sports Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and pharmacological evaluation of N-(3-carbamoyl-1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide derivatives as interleukin-1 receptor-associated kinase 4 inhibitors with reduced potential for cytochrome P450 1A2 induction.
Hiroshi Inami, Tsuyoshi Mizutani, Junko Watanabe, Hisashi Hayashida, Tomonori Ito

Bioorg Med Chem· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of spinal instability among patients with discogenic low back pain with different backgrounds.
Makoto Takahashi, Koji Iwamoto, Motoki Kuzuyama, Hiroshi Inami, Yuto Matsumoto

J Phys Ther Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effects of interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 on diabetic nephropathy in type 2 diabetic mice.
Mitsuhiro Kondo, Atsuo Tahara, Kazumi Hayashi, Hiroshi Inami, Takeshi Ishikawa

Naunyn Schmiedebergs Arch Pharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.
Hiroshi Inami, Jun-Ichi Shishikura, Tomoyuki Yasunaga, Masaaki Hirano, Takenori Kimura

Chem Pharm Bull (Tokyo)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.
Hiroshi Inami, Jun-ichi Shishikura, Tomoyuki Yasunaga, Kazushige Ohno, Hiroshi Yamashita

Bioorg Med Chem· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats.
Mitsuhiro Kondo, Atsuo Tahara, Kazumi Hayashi, Masaki Abe, Hiroshi Inami

Naunyn Schmiedebergs Arch Pharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.
Ippei Sato, Koichiro Morihira, Hiroshi Inami, Hirokazu Kubota, Tatsuaki Morokata

Bioorg Med Chem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition.
Ippei Sato, Koichiro Morihira, Hiroshi Inami, Hirokazu Kubota, Tatsuaki Morokata

Bioorg Med Chem· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
Ippei Sato, Koichiro Morihira, Hiroshi Inami, Hirokazu Kubota, Tatsuaki Morokata

Bioorg Med Chem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats.
Hiroshi Yamashita, Kazushige Ohno, Yoko Amada, Hiroshi Inami, Jun-Ichi Shishikura

Naunyn Schmiedebergs Arch Pharmacol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of fully kindled seizure and retardation of kindling acquisition by YM928 in the rat kindling model of epilepsy.
Hiroshi Yamashita, Kazushige Ohno, Hiroshi Inami, Jun-ichi Shishikura, Shuichi Sakamoto

Eur J Pharmacol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats.
Hiroshi Yamashita, Kazushige Ohno, Yoko Amada, Hanae Hattori, Yukiko Ozawa-Funatsu, Hiroshi Inami

J Pharmacol Exp Ther· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis